- Report
- September 2022
- 30 Pages
Global
From €2958EUR$3,250USD£2,512GBP
- Webinar
- February 2023
- 4 Hours
Global
From €894EUR$982USD£759GBP
- Webinar
- November 2022
- 4 Hours
Global
From €893EUR$982USD£759GBP
- Book
- April 2013
- 488 Pages
Global
- Book
- January 2016
- 472 Pages
- Book
- June 2020
- 365 Pages
- Book
- October 2023
- 336 Pages
- Book
- October 2023
- 336 Pages
The Nonclinical Study market is a segment of the Drug Discovery industry that focuses on the preclinical development of new drugs. This includes the testing of potential drugs on animals and in vitro systems to assess safety and efficacy. Nonclinical studies are conducted to determine the pharmacokinetics, pharmacodynamics, and toxicology of a drug before it is tested in humans. These studies are essential for the development of safe and effective drugs.
The Nonclinical Study market is highly competitive, with many companies offering services such as drug discovery, preclinical development, and toxicology testing. Companies in this market include Charles River Laboratories, Covance, PPD, WuXi AppTec, and Eurofins Scientific. Show Less Read more